BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 112999
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.112999
Table 1 Patterns of switching between different glucagon-like peptide-1 receptor agonists, n (%)

Total (70645)
Switched [18047 (25.5)]
Exenatide BID
Liraglutide
Lixisenatide
Exenatide ER
Dulaglutide
Semaglutide
Daily GLP-1RA3069910144 (33)
Exenatide BID1624775 (47.7)-6731371180
Liraglutide275968905 (32.2)199-553114840442961
Lixisenatide1479464 (31.4)0161-8520117
Weekly GLP-1RA399557903 (19.8)
Exenatide ER48961755 (35.8)-33869-1187161
Dulaglutide300625783 (19.2)058413113-5073
Semaglutide4997365 (7.3)01800347-


Write to the Help Desk